Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

Loyola opens Sexual Wellness Clinic in September

Loyola University Health System will open a Sexual Wellness Clinic in September. This program will combine the expertise of various specialists to address common emotional and physical challenges that couples face in their sexual relationships.

19 Aug 2013

Researchers identify stem cells in urine can be directed to become multiple cell types

Could harvesting stem cells for therapy one day be as simple as asking patients for a urine sample? Researchers at Wake Forest Baptist Medical Center's Institute for Regenerative Medicine and colleagues have identified stem cells in urine that can be directed to become multiple cell types.

31 Jul 2013

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Forest Laboratories, Inc. and Pierre Fabre Laboratories announced today that FETZIMA (levomilnacipran extended-release capsules), a once-daily serotonin and norepinephrine reuptake inhibitor, discovered by Pierre Fabre Laboratories and co-developed by Forest Laboratories, Inc. was approved by the U.S. Food and Drug Administration for the treatment of Major Depressive Disorder in adults.

26 Jul 2013

Elekta gets CE Mark approval for Clarity 4D Monitoring system

Elekta has received CE marking for its Clarity 4D Monitoring system permitting European clinics to implement this new way of reducing the uncertainty caused by prostate motion during radiation treatment. Physicians will be able to monitor the motion of the prostate with sub millimeter accuracy during the delivery of therapeutic radiation beams.

From Elekta 19 Jul 2013

Feds shut down more than 1,600 fake online pharmacies

Authorities from the Food and Drug Administration closed these illegal pharmacy websites and sent letters to hundreds more that sell counterfeit prescription drugs and dangerous supplements.

29 Jun 2013

First Edition: June 28, 2013

Today's headlines include reports that the high court sent a tentative signal Thursday that it was moving toward hearing a case on the regulation of abortion-inducing drugs.

28 Jun 2013

Eisai submits BELVIQ NDS with Health Canada

Arena Pharmaceuticals, Inc. announced today that Eisai Limited (based in Mississauga, Ontario), a subsidiary of Eisai Inc., has submitted a New Drug Submission for BELVIQ (lorcaserin HCl) with Health Canada.

26 Jun 2013

AtheroNova starts AHRO-001 Phase 1 clinical trial for treatment of atherosclerosis

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces achievement of a major milestone with the initiation of a Phase 1 clinical trial with its lead compound, AHRO-001. The Phase 1 study will evaluate the safety, tolerability and pharmacokinetics of AHRO-001 in healthy volunteers.

25 Jun 2013

Researchers develop method to identify aggressive prostate cancers

Researchers at Moffitt Cancer Center and colleagues at Louisiana State University have developed a method for identifying aggressive prostate cancers that require immediate therapy. It relies on understanding the genetic interaction between single nucleotide polymorphisms. The goal is to better predict a prostate cancer's aggressiveness to avoid unnecessary radical treatment.

20 Jun 2013

IPC to distribute AP's Promescent in US for treatment of premature ejaculation

The Independent Pharmacy Cooperative and Absorption Pharmaceuticals have signed a distribution agreement whereby IPC will make AP's topical treatment for premature ejaculation, Promescent, available to its 4,500+ member pharmacies throughout the United States.

14 Jun 2013

MHN, Auxilium Pharmaceuticals launch new health awareness program on Peyronie's disease

Men's Health Network and Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, have announced the launch of a new health awareness program called "Ask About the Curve" to provide information about Peyronie's disease and to help empower men to have meaningful discussions about their condition with their partner and their healthcare provider.

11 Jun 2013

Study suggests erectile dysfunction in young men may be more prevalent than previously thought

In a recent analysis of one outpatient clinic, one in four men seeking medical help for newly-developed erectile dysfunction (ED) was younger than 40 years, and nearly half of young men with the condition had severe ED.

7 Jun 2013

Study shows GreenLight laser therapy effective for BPH treatment

Data presented at the American Urological Association Annual Meeting demonstrate that treatment for Benign Prostatic Hyperplasia with GreenLight XPS laser therapy with MoXy fiber, instead of transurethral resection of the prostate, results in significantly shorter hospitalization, catheterization, and recovery times for patients, while maintaining equivalent safety and efficacy.

4 Jun 2013

Tibial nerve stimulation reduces symptoms of overactive bladder, research finds

Beaumont Health System research finds that symptoms of overactive bladder, or OAB, were reduced in those who received tibial nerve stimulation. The three-year results published in the June issue of The Journal of Urology show participants with urinary frequency, urgency and involuntary loss of urine maintained significant improvement in their symptoms.

31 May 2013

Research: Heart failure accelerates aging process, brings on early andropausal syndrome

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times more common in men with heart failure.

27 May 2013

Research finds number of links between dental health and overall health

If the eyes are the windows to your soul, then your mouth is the gateway to your overall health. Research has found a surprising number of links between the state of your dental health and your overall health.

23 May 2013

No significant benefit differences between IMRT and CRT therapies after prostatectomy

Use of the newer, more expensive intensity-modulated radiotherapy (IMRT) and use of the older conformal radiotherapy (CRT) after surgical removal of all or part of the prostate gland were associated with similar morbidity and cancer control outcomes, according to a study published Online First by JAMA Internal Medicine, a JAMA Network publication.

21 May 2013

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

Loyola opens Sexual Wellness Clinic in September

Researchers identify stem cells in urine can be directed to become multiple cell types

Forest Laboratories, Pierre Fabre Laboratories announce that FETZIMA gets FDA approval for MDD

Elekta gets CE Mark approval for Clarity 4D Monitoring system

Feds shut down more than 1,600 fake online pharmacies

First Edition: June 28, 2013

Eisai submits BELVIQ NDS with Health Canada

AtheroNova starts AHRO-001 Phase 1 clinical trial for treatment of atherosclerosis

Researchers develop method to identify aggressive prostate cancers

IPC to distribute AP's Promescent in US for treatment of premature ejaculation

MHN, Auxilium Pharmaceuticals launch new health awareness program on Peyronie's disease

Study suggests erectile dysfunction in young men may be more prevalent than previously thought

Study shows GreenLight laser therapy effective for BPH treatment

Tibial nerve stimulation reduces symptoms of overactive bladder, research finds

Research: Heart failure accelerates aging process, brings on early andropausal syndrome

Research finds number of links between dental health and overall health

No significant benefit differences between IMRT and CRT therapies after prostatectomy

UCLA study: Older men with multiple underlying health problems should avoid prostate cancer treatment

Patient compliance: an interview with Dr. Bassam Damaj, CEO of Innovus Pharma

Regularly taking prescription painkillers is associated with higher risk of ED in men

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Erectile Dysfunction News and Research

Latest Erectile Dysfunction News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in